Chemoinformaics analysis of Cycloart-25-Ene-3,24,27-Triol
| Molecular Weight | 458.727 | nRot | 6 |
| Heavy Atom Molecular Weight | 408.327 | nRig | 23 |
| Exact Molecular Weight | 458.376 | nRing | 5 |
| Solubility: LogS | -4.454 | nHRing | 0 |
| Solubility: LogP | 4.533 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 85.8456 |
| nHD | 3 | BPOL | 50.1604 |
| QED | 0.421 |
| Synth | 5.703 |
| Natural Product Likeliness | 3.353 |
| NR-PPAR-gamma | 0.29 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.872 |
| MDCK | 0.00002 |
| BBB | 0.699 |
| PPB | 0.940519 |
| VDSS | 1.195 |
| FU | 0.0371918 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.28 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.881 |
| CYP2c9-inh | 0.091 |
| CYP2c9-sub | 0.169 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.539 |
| CYP3a4-inh | 0.323 |
| CYP3a4-sub | 0.38 |
| CL | 9.754 |
| T12 | 0.036 |
| hERG | 0.045 |
| Ames | 0.055 |
| ROA | 0.189 |
| SkinSen | 0.535 |
| Carcinogencity | 0.042 |
| EI | 0.087 |
| Respiratory | 0.967 |
| NR-Aromatase | 0.507 |
| Antiviral | No |
| Prediction | 0.646184 |